Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 35, Issue 1, Pages -
Publisher
American Society for Microbiology
Online
2021-11-18
DOI
10.1128/cmr.00123-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
- (2021) Arnaud G. L’Huillier et al. CLINICAL MICROBIOLOGY AND INFECTION
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
- (2021) Jing-Hui Tian et al. Nature Communications
- Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
- (2021) William Ho et al. Advanced Healthcare Materials
- A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
- (2021) Abigail E. Powell et al. ACS Central Science
- Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
- (2021) Carlo Pifferi et al. Nature Reviews Chemistry
- Persistent cellular immunity to SARS-CoV-2 infection
- (2021) Gaëlle Breton et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- An Update on Self-Amplifying mRNA Vaccine Development
- (2021) Anna K. Blakney et al. Vaccines
- BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection but recognition of mutant viruses is up to 10‐fold reduced
- (2021) Xinyue Chang et al. ALLERGY
- A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
- (2021) Ruklanthi de Alwis et al. MOLECULAR THERAPY
- Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications
- (2021) Sergio A. Bernal-Chávez et al. MOLECULES
- Quadrivalent influenza nanoparticle vaccines induce broad protection
- (2021) Seyhan Boyoglu-Barnum et al. NATURE
- Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
- (2021) Xiaoying Shen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
- (2021) Susanne Rauch et al. npj Vaccines
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2
- (2021) Peter G. Kremsner et al. WIENER KLINISCHE WOCHENSCHRIFT
- Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets
- (2021) Shane Riddell et al. Frontiers in Immunology
- Three Emerging Coronaviruses in Two Decades
- (2020) Jeannette Guarner AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Nanoparticle-based delivery of self-amplifying RNA
- (2020) Kenneth Lundstrom GENE THERAPY
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Toward a universal flu vaccine
- (2020) Susanne Herold et al. SCIENCE
- A single dose polyanhydride-based nanovaccine against paratuberculosis infection
- (2020) Akanksha Thukral et al. npj Vaccines
- Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
- (2020) Sandra Jesus et al. Frontiers in Bioengineering and Biotechnology
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
- (2020) Manuel Becerra‐Flores et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
- (2020) Alec W. Freyn et al. MOLECULAR THERAPY
- Childhood vaccines and antibiotic use in low- and middle-income countries
- (2020) Joseph A. Lewnard et al. NATURE
- The coronavirus pandemic in five powerful charts
- (2020) Ewen Callaway et al. NATURE
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial
- (2020) Angus H. Forster et al. PLOS MEDICINE
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- OMV Vaccines and the Role of TLR Agonists in Immune Response
- (2020) Francesca Mancini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo
- (2020) Khalid A. Hajj et al. NANO LETTERS
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
- (2020) Jesse H. Erasmus et al. Science Translational Medicine
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
- (2020) George Ueda et al. eLife
- Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Joan B Soriano et al. Lancet Respiratory Medicine
- Why and How Vaccines Work
- (2020) Akiko Iwasaki et al. CELL
- Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection
- (2020) Gustavo Lou et al. JOURNAL OF CONTROLLED RELEASE
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
- (2020) Sandhya Bangaru et al. SCIENCE
- NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
- (2020) Mimi Guebre-Xabier et al. VACCINE
- A new generation of vaccines based on alphavirus self-amplifying RNA
- (2020) María Cristina Ballesteros-Briones et al. Current Opinion in Virology
- Reinfection with SARS-CoV-2: Implications for Vaccines
- (2020) Jeffrey I Cohen et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications
- (2019) Guangbao Yang et al. ADVANCED MATERIALS
- Branched-Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH
- (2019) Khalid A. Hajj et al. Small
- Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages
- (2019) Eun-Hye Bae et al. Journal of Innate Immunity
- New Vaccine Design and Delivery Technologies
- (2019) Masaru Kanekiyo et al. JOURNAL OF INFECTIOUS DISEASES
- Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus
- (2019) Leon Chien‐Wei Lin et al. ADVANCED FUNCTIONAL MATERIALS
- Biodegradable polymers for modern vaccine development
- (2019) Rajendran JC Bose et al. JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle
- (2019) Emilia Sokołowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- (2019) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
- (2019) Mahmoud M. Shehata et al. Vaccines
- Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells
- (2019) Frances C. Knight et al. ACS Nano
- Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity
- (2019) Daniel Sanchez-Guzman et al. BIOMATERIALS
- Chitosan as an environment friendly biomaterial – a review on recent modifications and applications
- (2019) Prasanna S. Bakshi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- Global Routine Vaccination Coverage, 2018
- (2019) Megan Peck et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells
- (2019) Tatsuya Kato et al. JOURNAL OF BIOTECHNOLOGY
- Advances in Biomaterials for Drug Delivery
- (2018) Owen S. Fenton et al. ADVANCED MATERIALS
- Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles
- (2018) Samah H. Mohamed et al. BIOLOGICALS
- Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
- (2018) Muhammad Riaz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microneedle arrays coated with charge reversal pH-sensitive copolymers improve antigen presenting cells-homing DNA vaccine delivery and immune responses
- (2018) Huu Thuy Trang Duong et al. JOURNAL OF CONTROLLED RELEASE
- Improving Vaccine and Immunotherapy Design Using Biomaterials
- (2018) Michelle L. Bookstaver et al. TRENDS IN IMMUNOLOGY
- Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)
- (2018) Germain J.P. Fernando et al. VACCINE
- Inactivated infectious bronchitis virus vaccine encapsulated in chitosan nanoparticles induces mucosal immune responses and effective protection against challenge
- (2018) Priscila Diniz Lopes et al. VACCINE
- Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults
- (2018) Xavier Sáez-Llorens et al. Human Vaccines & Immunotherapeutics
- Influenza
- (2018) Florian Krammer et al. Nature Reviews Disease Primers
- Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy
- (2018) Naihan Chen et al. JOURNAL OF CONTROLLED RELEASE
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens
- (2018) Tamiru Negash Alkie et al. PLoS One
- Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases
- (2017) P. Noel Barrett et al. Expert Review of Vaccines
- Polyethylenimine-based micro/nanoparticles as vaccine adjuvants
- (2017) Chen Shen et al. International Journal of Nanomedicine
- Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs
- (2017) Santosh Dhakal et al. JOURNAL OF CONTROLLED RELEASE
- Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery
- (2017) Brittany A. Bailey et al. MOLECULAR PHARMACEUTICS
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- The evolution of seasonal influenza viruses
- (2017) Velislava N. Petrova et al. NATURE REVIEWS MICROBIOLOGY
- Production of virus-like particles for vaccines
- (2017) J. Fuenmayor et al. New Biotechnology
- Systemic delivery of factor IX messenger RNA for protein replacement therapy
- (2017) Suvasini Ramaswamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The complexity and cost of vaccine manufacturing – An overview
- (2017) Stanley Plotkin et al. VACCINE
- Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
- (2017) Giulietta Maruggi et al. VACCINE
- Polyanhydride nanovaccine against swine influenza virus in pigs
- (2017) Santosh Dhakal et al. VACCINE
- Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin
- (2017) Mark R. Prausnitz Annual Review of Chemical and Biomolecular Engineering
- Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques
- (2017) Biliana Todorova et al. Scientific Reports
- Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae
- (2017) Liqin Wang et al. FEBS Open Bio
- Functional ferritin nanoparticles for biomedical applications
- (2017) Zhantong Wang et al. Frontiers of Chemical Science and Engineering
- Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
- (2017) Lázaro Moreira Marques Neto et al. Frontiers in Immunology
- Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
- (2017) Roland Böttger et al. PLoS One
- Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation
- (2016) Sivapriya Kailasan Vanaja et al. CELL
- Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
- (2016) Nazila Kamaly et al. CHEMICAL REVIEWS
- Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci
- (2016) Serena Giuntini et al. Clinical and Vaccine Immunology
- Chitosan: An Adjuvant with an Unanticipated STING
- (2016) Nicolas Riteau et al. IMMUNITY
- Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus
- (2016) Bin Zhou et al. JOURNAL OF VIROLOGY
- Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery
- (2016) Abhijeet P. Pandey et al. Materials Science & Engineering C-Materials for Biological Applications
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
- (2016) A. L. Silva et al. Human Vaccines & Immunotherapeutics
- Nanostructures for protein drug delivery
- (2016) Juliana de Almeida Pachioni-Vasconcelos et al. Biomaterials Science
- Long-term stability of influenza vaccine in a dissolving microneedle patch
- (2016) Matthew J. Mistilis et al. Drug Delivery and Translational Research
- pH-Responsive Poly(d,l-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response
- (2015) Qi Liu et al. ACS Nano
- Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months
- (2015) Fiona McQuaid et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Chitosan nanoparticle/PCL nanofiber composite for wound dressing and drug delivery
- (2015) Sang-Myung Jung et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review
- (2015) M.Abd Elgadir et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
- (2015) L. Marsay et al. JOURNAL OF INFECTION
- Development of a Thermostable Microneedle Patch for Influenza Vaccination
- (2015) Matthew J. Mistilis et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches
- (2015) Leonard Y. Chu et al. PHARMACEUTICAL RESEARCH
- Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device
- (2015) Dinah H. Amante et al. Human Gene Therapy Methods
- Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine
- (2015) Jose M. Jimenez-Guardeño et al. PLoS Pathogens
- Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
- (2014) Mohammad-Ali Shahbazi et al. BIOMATERIALS
- Gold nanoparticle conjugates: recent advances toward clinical applications
- (2014) Roberto Cao-Milán et al. Expert Opinion on Drug Delivery
- Skin permeabilization for transdermal drug delivery: recent advances and future prospects
- (2014) Carl M Schoellhammer et al. Expert Opinion on Drug Delivery
- Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8+ T cell responses
- (2014) Salka Keller et al. JOURNAL OF CONTROLLED RELEASE
- Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
- (2014) W. M. Bogers et al. JOURNAL OF INFECTIOUS DISEASES
- Gold Nanoparticles for Nucleic Acid Delivery
- (2014) Ya Ding et al. MOLECULAR THERAPY
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
- (2014) Jaeyun Kim et al. NATURE BIOTECHNOLOGY
- Biomaterials for Nanoparticle Vaccine Delivery Systems
- (2014) Preety Sahdev et al. PHARMACEUTICAL RESEARCH
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
- (2014) Cynthia M. Fehres et al. Frontiers in Immunology
- Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
- (2013) M. D. Snape et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection
- (2013) Jing Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
- (2013) Abdullah Assiri et al. LANCET INFECTIOUS DISEASES
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Tolerability of intramuscular and intradermal delivery by CELLECTRA®adaptive constant current electroporation device in healthy volunteers
- (2013) Malissa C Diehl et al. Human Vaccines & Immunotherapeutics
- Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles
- (2012) Seyed Davoud Jazayeri et al. JOURNAL OF CONTROLLED RELEASE
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Prediction and prevention of the next pandemic zoonosis
- (2012) Stephen S Morse et al. LANCET
- Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
- (2012) Dharmendra Raghuwanshi et al. MOLECULAR PHARMACEUTICS
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus
- (2012) Chia-Ying Wu et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- Nanovaccinology: The next generation of vaccines meets 21st century materials science and engineering
- (2012) Tewodros Mamo et al. VACCINE
- A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles
- (2012) Dharmendra Raghuwanshi et al. VACCINE
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
- (2011) Byoung-Shik Shim et al. BMC IMMUNOLOGY
- Biomedical applications of biodegradable polymers
- (2011) Bret D. Ulery et al. JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
- (2011) James J. Moon et al. NATURE MATERIALS
- Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza
- (2011) Nand Kishore Gupta et al. VACCINE
- Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
- (2011) A.I. Camacho et al. VACCINE
- Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation
- (2010) I. Tamayo et al. Clinical and Vaccine Immunology
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine
- (2010) Ladan Parhamifar et al. Soft Matter
- Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
- (2010) Zhiwei Sui et al. VACCINE
- Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a
- (2009) Shunsuke Kohyama et al. ANTIVIRAL RESEARCH
- Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
- (2009) Elodie Boisselier et al. CHEMICAL SOCIETY REVIEWS
- Evaluation of a Whole-Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B Neisseria meningitidis Vaccines Made from Lipid A Acylation Mutants
- (2009) M. B. Stoddard et al. Clinical and Vaccine Immunology
- SARS vaccines: where are we?
- (2009) Rachel L Roper et al. Expert Review of Vaccines
- Inspiration and application in the evolution of biomaterials
- (2009) Nathaniel Huebsch et al. NATURE
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
- (2009) Satoshi Ohno et al. VACCINE
- Influenza vaccines based on virus-like particles
- (2009) Sang-Moo Kang et al. VIRUS RESEARCH
- Epaxal®: a virosomal vaccine to prevent hepatitis A infection
- (2008) Patrick A Bovier Expert Review of Vaccines
- Nucleic acid delivery with chitosan and its derivatives
- (2008) Wing-Fu Lai et al. JOURNAL OF CONTROLLED RELEASE
- Poly(N-vinylformamide) Nanogels Capable of pH-Sensitive Protein Release
- (2008) Lianjun Shi et al. MACROMOLECULES
- Transdermal drug delivery
- (2008) Mark R Prausnitz et al. NATURE BIOTECHNOLOGY
- Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
- (2008) Kumari G. Lokugamage et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now